UC4 High Impact Research and Research Infrastructure Cooperative Agreement Programs - Multi-Yr Funding
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
This FOA will support the conduct of advanced clinical trials designed to test the outpatient clinical safety and efficacy of artificial pancreas (AP) device systems in type 1 diabetes with the objective of improving glycemic control and reducing acute and chronic complications of the disease. These trials should generate data able to satisfy safety and efficacy requirements by regulatory agencies regarding the clinical testing of AP device systems.
|Notice(s) for this Opportunity|
|Letter of Intent Due Date|
|Application Due Date|
April 15, 2015, by 5:00 PM local time of applicant organization. All types of non-AIDS applications
allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.